Product Information
DEXTROAMP-AMPHET ER 5 MG CAP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.4793 per EA under NDC 31722018501. Its NADAC has been published 232 times since Mar 16, 2022.
FDA first approved this application on Sep 29, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 5 MG CAP
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfateStrength
1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722018501
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA214959FDA Approved
9/29/2021
TE Code
AB1
On Market Since
9/29/2021
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 5 MG CAP has been published 232 times since Mar 16, 2022, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4793 per EA |
|---|---|
| All-time high | $0.9097 (Dec 13, 2023) |
| All-time low | $0.3459 (Apr 17, 2024) |
| 52-week high | $0.6090 |
| 52-week low | $0.4032 |
| Median price | $0.5855 |
| Average price | $0.5774 |
| Largest weekly change | +62.9% (Oct 18, 2023) |
| Weeks tracked | 232 |
| Tracking since | Mar 16, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 5 MG CAP, manufactured by Camber Pharmaceuticals Inc., is $0.4793 per EA (NDC 31722018501), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHET ER 5 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 5 MG CAP has declined 12.1%. It has been tracked across 232 weekly CMS publications since Mar 16, 2022.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 5 MG CAP?
Since Mar 16, 2022, the NADAC for DEXTROAMP-AMPHET ER 5 MG CAP has ranged from a low of $0.3459 (Apr 17, 2024) to a high of $0.9097 (Dec 13, 2023), with a median of $0.5855 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 5 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHET ER 5 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHET ER 5 MG CAP?
DEXTROAMP-AMPHET ER 5 MG CAP (NDC 31722018501) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.